News and blog posts
10
Feb 2020
We have released the interview on the Market Access Insider channel on Youtube. The interview covered key stakeholders, procedure coding, functioning of the DRG system, reimbursement processes for medical technologies in Switzerland. Michel discussed the biggest mistakes made by the Med Tech companies on the market and advised on the best strategy on how to approach the market.
Read more
07
Feb 2020
New material codes for a set of equipment for the quantification of collateral ventilation in isolated pulmonary compartments and unidirectional endobronchial valve with placement system were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in February 2020.
Read more
06
Feb 2020
The Federal Joint Committee (G-BA) has updated the nationwide requirements for disease management programs (DMP) for patients with type 1 diabetes mellitus. The current DMP contracts must then be adjusted to the new requirements within one year of the decision coming into force. Around 225,000 legally insured patients are currently enrolled in a DMP for type 1 diabetes.
Read more
05
Feb 2020
In late January 2020, the network of European HTA agencies, EUnetHTA, announced the final plan of the project OTCA21 “Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnoea.”
Read more
04
Feb 2020
In January 2020, the Reimbursement Commission made changes to the Healthcare Implementation Communique in Turkey. The main changes relate to the addition of new laboratory test codes, procedure codes, new devices related to the ophthalmology, and price changing of materials related to interventional radiology.
Read more
03
Feb 2020
The HTA unit of the Lombardy region opens the possibility for the public to comment on the health technologies which are in the assessment phase. The call is open until February 28, 2020.
Read more
03
Feb 2020
On the week of the 27th of January, MTRC published several posts related to the NABM procedure codes for IVD tests in France, the frequency of update of procedural classifications in Europe, and the least active countries in relation to the Med Tech HTA in Europe. Follow us on Instagram on @mtrc.market.access
Read more
31
Jan 2020
Norway established in 2013 a framework “New Method” for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. In this framework, all innovations should undergo HTA before being funded. In January 2020, four new mini-HTA projects of medical technologies were launched in Norway: robotic-assisted procedures, ear reconstruction, continuous electroencephalography, among others.
Read more
The costs for biomarker-based breast cancer testing covered by statutory health insurance in Germany
30
Jan 2020
From January 2020, the "Oncotype DX Breast Recurrence Score" test is reimbursed by the health insurance companies at an extra budget of 3,296.50€. This is explicitly the only test that the Federal Joint Committee (G-BA) has included in the contracted medical care.
Read more
29
Jan 2020
We have released the interview on the Market Access Insider channel on Youtube. Prof. Banfi gave an extensive introduction to the history and the current state of the health technology assessment in Italy. Also, the current state of the HTA program in Lombardy was discussed.
Read more
29
Jan 2020
New material code for a set of nets for the repair of prolapse (for vaginal placement) was added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in January 2020.
Read more
28
Jan 2020
In December 2019, the Norwegian Institute of Public Health released an HTA report regarding the effectiveness of uterine fibroids treatment commissioned by the Centre for joint decision-making to summarize the findings regarding this method. Embolization probably reduces the time that is needed to get back to the activity in comparison to myomectomy and hysterectomy.
Read more